Lipoprotein-associated phospholipase A2 (Lp‑PLA2)
|Men:||< 639 U/L|
|Women:||< 507 U/L|
Each laboratory should check if the reference ranges are transferable to its own patient population and determine own reference ranges if necessary. For diagnostic purposes, the results should always be assessed with the patient’s medical history, clinical examinations and other findings.
For information on clinical relevance, please refer to the package insert.
Lipoprotein-associated phospholipase A2 (Lp-PLA2) plays a major role in the development of atherosclerotic plaques, representing a beneficial indicator for cardiovascular disease (CVD) risks.